371 related articles for article (PubMed ID: 35997395)
1. The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review.
Halloran D; Pandit V; Nohe A
J Dev Biol; 2022 Jul; 10(3):. PubMed ID: 35997395
[TBL] [Abstract][Full Text] [Related]
2. Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management.
Lian H; Su M; Zhu Y; Zhou Y; Soomro SH; Fu H
Asian Pac J Cancer Prev; 2019 Jan; 20(1):23-32. PubMed ID: 30677865
[TBL] [Abstract][Full Text] [Related]
3. CK2.1, a novel peptide, induces articular cartilage formation in vivo.
Akkiraju H; Bonor J; Nohe A
J Orthop Res; 2017 Apr; 35(4):876-885. PubMed ID: 27312334
[TBL] [Abstract][Full Text] [Related]
4. Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies.
Gowda C; Sachdev M; Muthusami S; Kapadia M; Petrovic-Dovat L; Hartman M; Ding Y; Song C; Payne JL; Tan BH; Dovat S
Curr Pharm Des; 2017; 23(1):95-107. PubMed ID: 27719640
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.
Gibson SA; Yang W; Yan Z; Liu Y; Rowse AL; Weinmann AS; Qin H; Benveniste EN
J Immunol; 2017 Jun; 198(11):4244-4254. PubMed ID: 28468969
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons.
Lettieri A; Borgo C; Zanieri L; D'Amore C; Oleari R; Paganoni A; Pinna LA; Cariboni A; Salvi M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779225
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase CK2 in development and differentiation.
Götz C; Montenarh M
Biomed Rep; 2017 Feb; 6(2):127-133. PubMed ID: 28357063
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells.
Schwind L; Wilhelm N; Kartarius S; Montenarh M; Gorjup E; Götz C
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2207-16. PubMed ID: 26025678
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer.
Husain K; Williamson TT; Nelson N; Ghansah T
Immunol Med; 2021 Sep; 44(3):159-174. PubMed ID: 33164702
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Protein Kinase CK2 Prevents Adipogenic Differentiation of Mesenchymal Stem Cells Like C3H/10T1/2 Cells.
Schwind L; Schetting S; Montenarh M
Pharmaceuticals (Basel); 2017 Feb; 10(1):. PubMed ID: 28208768
[TBL] [Abstract][Full Text] [Related]
11. ROCK2-Specific Inhibitor KD025 Suppresses Adipocyte Differentiation by Inhibiting Casein Kinase 2.
Tran NNQ; Chun KH
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443331
[TBL] [Abstract][Full Text] [Related]
12. Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945.
Rosales M; Rodríguez-Ulloa A; Besada V; Ramón AC; Pérez GV; Ramos Y; Guirola O; González LJ; Zettl K; Wiśniewski JR; Perera Y; Perea SE
Cells; 2021 Feb; 10(2):. PubMed ID: 33562780
[TBL] [Abstract][Full Text] [Related]
13. Identification of Candidate Casein Kinase 2 Substrates in Mitosis by Quantitative Phosphoproteomics.
Rusin SF; Adamo ME; Kettenbach AN
Front Cell Dev Biol; 2017; 5():97. PubMed ID: 29214152
[TBL] [Abstract][Full Text] [Related]
14. CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death.
Mandato E; Nunes SC; Zaffino F; Casellato A; Macaccaro P; Tubi LQ; Visentin A; Trentin L; Semenzato G; Piazza F
Curr Cancer Drug Targets; 2018; 18(6):608-616. PubMed ID: 28460620
[TBL] [Abstract][Full Text] [Related]
15. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP
Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138
[TBL] [Abstract][Full Text] [Related]
16. Expanding roles of protein kinase CK2 in regulating plant growth and development.
Mulekar JJ; Huq E
J Exp Bot; 2014 Jun; 65(11):2883-93. PubMed ID: 24307718
[TBL] [Abstract][Full Text] [Related]
17. Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.
Agarwal M; Nitta RT; Li G
J Mol Genet Med; 2013 Dec; 8(1):. PubMed ID: 25264454
[TBL] [Abstract][Full Text] [Related]
18. Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
Richter A; Sender S; Lenz A; Schwarz R; Hinz B; Knuebel G; Sekora A; Murua Escobar H; Junghanss C; Roolf C
BMC Cancer; 2020 Mar; 20(1):184. PubMed ID: 32131762
[TBL] [Abstract][Full Text] [Related]
19. The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies.
Chon HJ; Bae KJ; Lee Y; Kim J
Front Pharmacol; 2015; 6():70. PubMed ID: 25873900
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase CK2 in human diseases.
Guerra B; Issinger OG
Curr Med Chem; 2008; 15(19):1870-86. PubMed ID: 18691045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
